Common Contracts
3 similar Consortium Agreement contracts by WuXi PharmaTech (Cayman) Inc.
SECOND AMENDED AND RESTATED CONSORTIUM AGREEMENTConsortium Agreement • October 20th, 2015 • WuXi PharmaTech (Cayman) Inc. • Pharmaceutical preparations • New York
THIS SECOND AMENDED AND RESTATED CONSORTIUM AGREEMENT, dated as of October 20, 2015 (this “Agreement”), is made by and among Dr. Ge Li (the “Chairman”), ABG II-WX Limited, a company formed under the laws of the British Virgin Islands (“ABG”), Boyu Capital Fund II, L.P., an exempted limited partnership formed under the laws of the Cayman Islands (“Boyu” and, together with ABG, the “Initial Sponsors”), G&C Partnership L.P., an exempted limited partnership formed under the laws of the Cayman Islands (“G&C”), Temasek Life Sciences Private Limited, a limited company formed under the laws of Singapore (“Temasek”), Hillhouse Capital Fund II, L.P., an exempted limited partnership formed under the laws of the Cayman Islands (“Hillhouse”), Ping An Life Insurance Company of China, Ltd. (Registration No. 100000000037463), a joint stock limited company formed under the laws of the People’s Republic of China (the “PRC”) (“Ping An”), G&C IV Limited, a company incorporated under the laws of the Cayman
AMENDED AND RESTATED CONSORTIUM AGREEMENTConsortium Agreement • September 1st, 2015 • WuXi PharmaTech (Cayman) Inc. • Pharmaceutical preparations • New York
THIS AMENDED AND RESTATED CONSORTIUM AGREEMENT, dated as of July 2, 2015 (this “Agreement”), is made by and among Dr. Ge Li (the “Chairman”), ABG Capital Partners II GP, L.P., an exempted limited partnership formed under the laws of the Cayman Islands (“ABG”), Boyu Capital Fund II, L.P., an exempted limited partnership formed under the laws of the Cayman Islands (“Boyu” and, together with ABG, the “Initial Sponsors”), Temasek Life Sciences Private Limited, a limited company formed under the laws of Singapore (“Temasek”), Hillhouse Fund II, L.P., an exempted limited partnership formed under the laws of the Cayman Islands (“Hillhouse”) and Ping An Insurance (Group) Company of China. Ltd., a joint stock limited company formed under the laws of the People’s Republic of China (the “PRC”) (“Ping An”). Each of the Chairman, ABG, Boyu and Temasek is referred to herein as a “Principal Consortium Member” and, collectively, as the “Principal Consortium Members”. Each of the Principal Consortium M
CONSORTIUM AGREEMENTConsortium Agreement • September 1st, 2015 • WuXi PharmaTech (Cayman) Inc. • Pharmaceutical preparations • New York
THIS CONSORTIUM AGREEMENT, dated as of May 11, 2015 (this “Agreement”), is made by and among Dr. Ge Li (the “Chairman”), ABG Capital Partners II GP, L.P., an exempted limited partnership formed under the laws of the Cayman Islands (“ABG”) and Boyu Capital Fund II, L.P., an exempted limited partnership formed under the laws of the Cayman Islands (“Boyu” and, together with ABG, the “Initial Sponsors”). Each of the Chairman, ABG and Boyu is referred to herein as a “Principal Consortium Member” and, collectively, as the “Principal Consortium Members”. Each of the Principal Consortium Members and any Additional Sponsor admitted to the Consortium after the date hereof pursuant to the terms of this Agreement is referred to herein as a “Party”, and collectively, the “Parties”. Unless otherwise defined herein, capitalized terms used herein shall have the meanings assigned to them in Section 10.1 hereof.
